Rekombinanter ADRA2A Antikörper
Kurzübersicht für Rekombinanter ADRA2A Antikörper (ABIN7572308)
Target
Alle ADRA2A Antikörper anzeigenAntikörpertyp
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Recombinant Anti-Alpha-2A adrenergic receptor Antibody (N379/52)
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
-
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Andere Bezeichnung
- Alpha-2A adrenergic receptor
-
Hintergrund
- ADRA2A, ADRAR, Alpha-2A adrenergic receptor, ADRA2R, Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, Alpha-2AAR
-
Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Target
-